IGFBP7 and glioma: Similarly, IGFBP7 hyper‐methylated glioma had higher clinical overall survival compared with IGFBP7 hypo‐methylated glioma in TCGA‐GBMLGG and CGGA‐GBMLGG datasets (Figure 7F).